Publicacions
-
Fernández-Cooke E, Barrios Tascón A, Antón-López J, Grasa Lozano CD, Sánchez-Manubens J and Calvo-Benet C.
Infecciones previas o coincidentes con la sospecha de enfermedad de Kawasaki ¿debemos cambiar nuestra actitud?
ANALES DE PEDIATRIA . 90(4): 213-218. Nº de cites: 5
-
Sánchez-Manubens J, Iglesias-Jimenez E and Anton-Lopez J.
Canakinumab for the treatment of hyperimmunoglobulin D syndrome
EXPERT REVIEW OF CLINICAL IMMUNOLOGY . 15(3): 215-220. Nº de cites: 7
-
Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Rodó X and Morguí JA.
Kawasaki disease is more prevalent in rural areas of Catalonia (Spain)
ANALES DE PEDIATRIA . 87(4): 226-231. Nº de cites: 4
-
Sánchez-Manubens J, Gelman A, Franch N, Teodoro S, Palacios JR, Rudi N, Rivera J and Anton-Lopez J.
A child with resistant Kawasaki disease successfully treated with anakinra: a case report
BMC PEDIATRICS . 17: 102-102. Nº de cites: 32
-
Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Borlan S, Gimenez-Roca C and Rivera J.
Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population
RHEUMATOLOGY INTERNATIONAL . 36(7): 905-910. Nº de cites: 29
-
Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E and Calzada-Hernández J.
Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 34(3): 139-144. Nº de cites: 15
-
Calzada-Hernández J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Ricart S, Martín-de-Carpi J, García de Vicuña-Muñoz C, Torrente V, Sánchez-Manubens J, Giménez-Roca CI, Rozas L, Juncosa-Morros T, Fortuny-Guasch C and Noguera-Julián A.
Tuberculosis in pediatric patients treated with anti-TNFa drugs: a cohort study
PEDIATRIC RHEUMATOLOGY . 13: 54-54. Nº de cites: 33
-
Giménez-Roca CI, Iglesias-Jimenez E, Torrente-Segarra V, Bou-Torrent R, Sánchez-Manubens J, Calzada-Hernández J, Samuel Hernandez Baldizon, Ricart S and Anton-Lopez J.
Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
RHEUMATOLOGY INTERNATIONAL . 35(2): 323-326. Nº de cites: 12
-
Iglesias-Jimenez E, Torrente V, Bou-Torrent R, Ricart S, Maria Isabel Gonzalez Fernandez, Sánchez-Manubens J, Calzada-Hernández J and Anton-Lopez J.
Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-alpha therapy: a clinical practice observational study of patients who discontinued treatment
RHEUMATOLOGY INTERNATIONAL . 34(8): 1053-1057. Nº de cites: 22
-
Sánchez-Manubens J, Bou-Torrent R and Anton-Lopez J.
Diagnosis and classification of Kawasaki disease
JOURNAL OF AUTOIMMUNITY . 48-49: 113-117. Nº de cites: 48